Medscape Medical News
- Alert EMA Panel Endorses Approval of Five New Cancer Drugs
- EMA Panel Backs Roclanda Eyedrops, New Option for Glaucoma
- Alert EMA Panel Backs Xofluza for Influenza, Post-Exposure Prophylaxis
- Alert EMA Recommends First Long-Acting Injectable HIV Treatment
- Alert EMA OKs First CAR T-Cell Therapy for Mantle Cell Lymphoma
- New FreeStyle Libre Glucose Monitoring System Gets EU Approval
- Alert EMA Panel Backs Baricitinib for Moderate-to-Severe Atopic Dermatitis
- Alert EMA Backs Dexamethasone for Severe COVID-19 After Data Review
- Alert EMA Backs Dapivirine Vaginal Ring for HIV Prevention Outside of EU
- Alert EMA Green Light for Avapritinib for GIST, Acalabrutinib for CLL
- Alert CHMP Backs Bupivacaine/Meloxicam (Zynrelef) for Postop Pain
- Alert EU Gives Thumb Up for Belantamab in R/R Multiple Myeloma
- Alert EU Green Light for Canagliflozin to Slow Diabetic Kidney Disease
- Alert EU Panel Backs Triple Combo Asthma Inhaler With Digital Sensor
- Alert Sanofi's Biosimilar Insulin Aspart Gets Green Light in EU
- Alert EU Panel OKs Glasdegib for AML and Luspatercept for MDS
- EMA Panel Backs Pretomanid for Drug-Resistant TB
- Alert EMA Backs Fluad Tetra for Influenza Prophylaxis in the Elderly
- Alert EMA Panel Backs Zolgensma Gene Therapy for SMA
- Alert EMA Panel Backs Two Antibacterials